CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2700
+0.0200 (8.00%)
Nov 14, 2025, 4:00 PM EST
CytoDyn Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
333.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | - | - | - |
| May 31, 2024 | - | - | - |
| May 31, 2023 | - | - | - |
| May 31, 2022 | 266.00K | - | - |
| May 31, 2021 | - | - | - |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Mid-Atlantic Home Health Network | 27.00M |
| Silence Therapeutics | 25.83M |
| China New Energy Group Co. | 12.51M |
CytoDyn News
- 13 days ago - CytoDyn (CYDY) Secures $30 Million Funding Commitment from Yorkville - GuruFocus
- 13 days ago - CytoDyn (CYDY) Secures $30M Funding for Cancer Drug Development - GuruFocus
- 13 days ago - CytoDyn secures $30M equity funding commitment - Seeking Alpha
- 13 days ago - CytoDyn Secures $30 Million Commitment from Yorkville Advisors - GlobeNewsWire
- 25 days ago - Halper Sadeh LLC Encourages CytoDyn Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 5 weeks ago - CytoDyn to Present at the LD Micro Main Event XIX Investor Conference - GlobeNewsWire
- 6 weeks ago - September 2025 Letter to Shareholders - GlobeNewsWire
- 7 weeks ago - CytoDyn (CYDY) Highlights Promising Cancer Research at AACR Conference - GuruFocus